BusinessVaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s DiseaseBy Nasdaq OMXJan 30, 2018, 4:14 PM UTC
BusinessVaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung CancerBy Nasdaq OMXOct 6, 2016, 1:45 PM UTC
